Featured tickers: $ABBV $AGIO $ALNY $AMRN $ARWR $CEMP $CRDC $ESPR $FMI $GILD $ISRG $NSPH $PPHM $PSDV $SHPG $SNSS
@ashishkjha Amazing thing about 'missteps in medicine' is that it tends to cluster and cascade. Just like excellence.
— Amitabh Chandra (@amitabhchandra2) October 12, 2014 @Sport234a 80% of the bio #ipo s have been crap this year & the other 20% have acted like crap
— Dan Rosenblum (@sharkbiotech) October 13, 2014 #siu14 $isrg Another description of the uselessness of robo-ing where disease is not prevalent and MDs not trained
— daviesbj (@daviesbj) October 13, 2014 $ALNY clearly has learned how to manage expectations, unlike $ARWR. In the end, it is not about expectation mgmt, but data.
— Dirk Haussecker (@RNAiAnalyst) October 13, 2014 You own 2 pennies, aka 2% of a $1 bill. If you lose one penny, did the % you own go down by 1% or 50%? Don't know? Quit writing publicly.
— David Miller (@AlpineBV_Miller) October 13, 2014 Seeing many new increased price targets for many names...the pumps don't seem to be working...
— Joe Prete, Pharm.D. (@JoeP450) October 13, 2014 Those of us living with mets are aware of the disease every day. A cancer diagnosis changes you. So does a mets diagnosis #bcsm
— Jody Schoger (@jodyms) October 14, 2014 widgets.js" charset="utf-8"> Small caps up 1% pre market. $IWM Wouldnt take much in the way of earnings to flip sentiment.
— Emory Redd (@Emory_R) October 14, 2014 $crdc adds $nsph former ceo to board. Guess they really want to botch the launch
— NathanAaron (@NathanAhron) October 14, 2014 $amrn should move out of Ireland. They have no "luck of the Irish." FDA cancels their SPA in 11th hour; epanova gets bought out over them...
— Joe (@Drchik23) October 15, 2014 @bradloncar hope they stick a nail in the coffin for all these deals so cos go hunting for real M&A drugs instead of inverting to prosperity
— Colfax (@ColfaxCapital) October 15, 2014 On the bright side $AGIO is strong (again) in a weak market.
— David Sobek (@dsobek) October 15, 2014 The harvoni tsunami is hitting me today. I have placed 15 orders so far today. The public health system is definitely going bankrupt $gild
— biotechnicality (@biotechnicality) October 15, 2014 The fraud of $PPHM may never be topped by their Ph2 data fiasco. Funny how they never found out what happened
— Patrick (@chasingthealpha) October 15, 2014 @dsobek in today's market $3B worth of curative Hepatitis drug is only equivalent to a few hazmat suits, a respirator and some plastic cups.
— David Maizenberg (@biologypartners) October 10, 2014 It gets real hard to keep reassuring people when Texas Presbyterian keeps finding new and creative ways to freak everyone out.
— Dr. Ed (@EdInTheICU) October 15, 2014 NASDQ was down 100 points at 1:30 pm
— Colfax (@ColfaxCapital) October 15, 2014 Seeing lots of gadgets for healthy young & rich but not for people with real healthcare needs, says @HealthcareWen at @HealthTechCap conf
— Lisa Suennen (@VentureValkyrie) October 15, 2014 $CEMP: Solithro, Takesta and a Top CEO ... Cemp ...per fi!
— Tricia Dineen (@MsTriciaD) October 16, 2014 Not calling a bottom in anything but if you have a watchlist and can't buy at least 1 starter today what are you waiting for?
— Festo (@Festo50) October 15, 2014 $XBI +7.8% over the last three days.
— Brad Loncar (@bradloncar) October 16, 2014 Excited about OPEX tomorrow. Collect 100% on some biotech graveyard written calls. $snss $arwr $psdv. Hopefully. No jinx
— DeadCatBill (@getbillasap) October 16, 2014 Chantix vote: 11 to keep boxed warning as is, 6 to modify but keep boxed warning, 1 to remove it.
— Ramsey Baghdadi (@Ramsey_Baghdadi) October 16, 2014 Incremental +ve for $FMI- Priority Health covering Foundation One/Heme, first health plan to do so. Hope its first of many, and soon
— Vikram Khanna (@VikramKhanna_) October 16, 2014 Wow, ESPR pricing- totally missed tone change.Last week has put spooks on funds increasing "risk" exposure...Likely readthru to IPOs on file
— Vikram Khanna (@VikramKhanna_) October 16, 2014 
RSS Feed
